Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.
Will E, Bailey J, Schuesler T, Modlich U, Balcik B, Burzynski B, Witte D, Layh-Schmitt G, Rudolph C, Schlegelberger B, von Kalle C, Baum C, Sorrentino BP, Wagner LM, Kelly P, Reeves L, Williams DA.
Will E, et al. Among authors: bailey j.
Mol Ther. 2007 Apr;15(4):782-91. doi: 10.1038/sj.mt.6300083. Epub 2007 Feb 13.
Mol Ther. 2007.
PMID: 17299409
Free article.